Title: Targeting TNF-alpha for the treatment of inflammatory bowel disease
Authors: Billiet, Thomas ×
Rutgeerts, Paul
Ferrante, Marc
Van Assche, Gert
Vermeire, Severine #
Issue Date: 2014
Publisher: Ashley Publications Ltd.
Series Title: Expert Opinion on Biological Therapy vol:14 issue:1 pages:75-101
Article number: 10.1517/14712598.2014.858695
Abstract: The advent of tumor necrosis factor (TNF) antagonists represented a radical change in the management of inflammatory bowel disease (IBD). Both in short- and long-term, anti-TNF therapy has been shown to reduce symptoms, heal mucosal ulcers, reduce hospitalizations and surgeries and spare corticosteroids.
ISSN: 1471-2598
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Non-KU Leuven Association publications
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science